Kyowa Hakko Introduces the World's First Postbiotic Eye Gummy
In a remarkable advancement for eye health, Kyowa Hakko USA has unveiled the world's first postbiotic eye gummy, featuring its proprietary ingredient, EYEMUSE®. This innovative product is incorporated into Zen Nutrients' THE EYE-MAZEN GUMMY line, catering to both adults and children.
The Science Behind EYEMUSE®
EYEMUSE® is derived from a specific heat-treated strain of probiotic known as Lacticaseibacillus paracasei KW3110. Developed by Kyowa Hakko's parent company, Kirin Holdings in Japan, this postbiotic ingredient is scientifically designed to support eye health. Research indicates that EYEMUSE® helps alleviate digital eye fatigue and discomfort caused by prolonged screen time, a common issue in today's digital age.
In vitro studies back the claims, suggesting that EYEMUSE® might even protect against harmful blue light emitted by digital devices. "Quality and science come first, so our partners can formulate with confidence and communicate with care," stated Katie Emerson, Senior Manager of Scientific Affairs at Kyowa Hakko USA. This emphasis on science ensures that consumers receive a product grounded in reliable research.
Benefits of EYEMUSE®
Particularly for those who spend significant hours in front of screens, EYEMUSE® offers a much-needed relief. Clinical studies from Japan have revealed that Lacticaseibacillus paracasei KW3110 not only helps soothe eye fatigue but also improves visual performance through indicators like critical flicker frequency, a measure of eye stamina under stress. Laboratory research further clarifies that this postbiotic aids the eyes in filtering blue light, promoting comfort during extended digital exposure.
The Eye-Mazen Gummy Concept
The idea for THE EYE-MAZEN GUMMY came from pharmacist Devan Patel, who sought to provide a solution for his daughter's screen-related eye strain. This gummy combines EYEMUSE® with Cognizin®, another of Kyowa Hakko's acclaimed ingredients known for its brain health benefits, into a user-friendly format. "Today's screen-heavy lifestyles necessitate modern nutritional support for families," Patel explained in a recent interview, highlighting the need for such innovative products in today's marketplace.
Accessibility and Usage
The launch of THE EYE-MAZEN GUMMY represents a fusion of scientific robustness and practical wellness. Available through the Zen Nutrients website, these gummies offer detailed ingredient information and age-specific usage guidelines, reflecting a commitment to supporting eye health for families navigating a world dominated by screens.
Conclusion
Kyowa Hakko's EYEMUSE® postbiotic eye gummy marks a significant milestone in the health supplement industry, addressing a prevailing concern of modern consumers. By bridging advanced science with everyday needs, this product aims to make eye comfort accessible, fostering healthier habits for digital device users of all ages. For more information on EYEMUSE® and its benefits, visit
EYEMUSEhealth.com.
About KYOWA HAKKO USA
Kyowa Hakko USA operates as the North and South American division of Kyowa Hakko Bio Co., Ltd. This company is recognized globally for its innovative health ingredients in pharmaceuticals, nutraceuticals, and food and beverage sectors. Their product portfolio includes other well-known ingredients like Cognizin® and Pantesin®.
Explore the changes in eye care and how these gummies could potentially reshape the way we approach eye health in our tech-centric world. This launch is not merely a product introduction, but represents a shift towards more proactive, health-oriented living for everyone involved.